Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Acetarsol-containing product |
Is a |
Product containing arsenic (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Topical antipruritic (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Antiprotozoal drug |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Acetarsone |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Acetarsol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Arsenic compound |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antineoplastic agent (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cutané |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Arsenic |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Product containing antitrichomonal |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Product containing amebicide |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Product containing arsenic and/or arsenic compound (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Medicinal product categorized by disposition (product) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Is a |
Medicinal product acting as antiprotozoal agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Acetarsol-containing product |
Plays role |
Antiprotozoal therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|